Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of AK-120 (famciclovir) in Recurrent Herpes Simplex
jRCT2080223168Phase 3Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in herpes simplex (HSV) comparing Famciclovir (AK-120) with Placebo (2 arms). Started Apr 2016; status: completed.
02
Drugs
famciclovir
03
Conditions
herpes simplex (HSV)
Beyond the preview
Go deeper on jRCT2080223168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223168.